{'fraction_non_alphanumeric': 0.023915832691814215, 'fraction_numerical': 0.015242494226327945, 'mean_word_length': 5.409868421052631, 'pattern_counts': {'":': 0, '<': 2, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
Racial and Ethnic Disparities in Rates of Invasive Second Breast Cancer Among Women With Ductal Carcinoma In Situ in Hawaiʻi

Key Points Question Is there variation in the risk for developing an invasive second breast cancer (SBC) among women with an initial diagnosis of ductal carcinoma in situ who are from racial and ethnic minority populations? Findings This cohort study including 6221 women found that Native Hawaiian and Filipino women were at significantly higher risk than White women of developing both invasive ipsilateral SBC and invasive contralateral SBC. Meaning This study suggests that understanding the racial and ethnic differences in the potential risk of invasive SBC using data sets with a more diverse population may help guide clinical treatment and screening decisions for at-risk subpopulations.


Introduction
Invasive breast cancer is the most common cancer among US women, with more than 280 000 diagnoses and 40 000 deaths expected in 2021. 1 It remains the leading cause of death for women 20 to 59 years of age, and improvements in mortality have steadily plateaued across age groups. 1 With improvements in mammography screening, the number of noninvasive ductal carcinoma in situ (DCIS) diagnoses has increased. 2 Although DCIS outcomes are generally favorable, up to 40% of women develop a second breast cancer (SBC) after DCIS, 28% of which are invasive breast cancers. 3,4 Optimal therapeutic and clinical follow-up strategies for DCIS remain a topic of discussion and warrant attention to prevent potential overtreatment of women with low-risk disease and undertreatment of women at high risk of developing an invasive SBC. 5 Understanding which women are at risk for developing a subsequent invasive SBC is important to optimally individualize treatment and management.
Racial and ethnic disparities exist among women with DCIS who develop invasive SBC. [6][7][8][9][10] Native Hawaiian or Other Pacific Islander (NHPI) individuals are 1 of the 5 federally recognized, legally disaggregated US racial categories 11 and are among the fastest growing populations in the US. 12 It is becoming increasingly recognized that disaggregating NHPI individuals from other racial and ethnic groups reveals marked health disparities because NHPI individuals have some of the highest cancer mortality rates, the highest chronic disease incidence rates, and the shortest life spans. 11,[13][14][15] Hawaiian or Other Pacific Islander women have a higher overall incidence of cancer, including breast cancer, than all Asian American women. 1,[15][16][17] The true cancer incidence among NHPI individuals is reduced by up to half when NHPI individuals are aggregated with Asian American individuals. 1,16,17 Native Hawaiian women have among the highest rates of breast cancer, with rates nearly 4 times higher than those among Asian women. 16 Nonetheless, most breast cancer studies continue to aggregate NHPI individuals, and little is known about how NHPI race is associated with prognostication.
Given the importance of optimizing prognostication of women who develop invasive SBC after a DCIS diagnosis, this study aimed to understand the prevalence of invasive SBC among the diverse population in Hawai'i and identify risk factors associated with developing invasive ipsilateral SBC (iiSBC) and invasive contralateral SBC (icSBC).

Data Sources and Study Population
country of NHPI individuals and individuals of some Asian ethnicities. 19 Patient data, including demographic, clinical, pathologic, and first-course treatment information, are collected and classified according to uniform national standards. 20,21 This research was approved as being exempt by the University of Hawai'i institutional review board and patient informed consent was waived because the data were deidentified. This study followed the Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) reporting guideline.
The study population was composed of female residents of Hawai'i aged 20 years or older who received a diagnosis of a first primary DCIS breast cancer between January 1, 1973, and December 31, 2017. Among these DCIS cases, women with or without a subsequent diagnosis of invasive SBC were evaluated. Women with invasive SBC less than 6 months after their first primary DCIS breast cancer were excluded owing to the possibility of confounding residual or recurrent disease. Patient demographic, clinical, pathologic, and treatment characteristics were evaluated based on the initial DCIS breast cancer diagnoses. Invasive ipsilateral SBC and icSBC were defined by laterality (left vs right) of the first DCIS compared with the invasive SBC, including all quadrants of the disease. Clinical and pathologic characteristics included grade, histologic characteristics, hormone status, and laterality. First course of therapy was classified as breast-conserving surgery (BCS) alone, BCS and radiotherapy (RT), BCS and systemic therapy (chemotherapy and/or hormonal therapy) with or without RT, mastectomy only, mastectomy and systemic treatment, or no treatment. Breast cancer subtype information was available for a subset of patients and was based on the expression of estrogen receptor (ER) and/or progesterone receptor (PR). Self-reported racial and ethnic classifications included the 5 major racial and ethnic populations of Hawai'i (Native Hawaiian, White, Japanese, Chinese, and Filipino). To preserve anonymity, less-populous racial and ethnic groups were collectively classified as "minority race and ethnicity," which included individuals self-identifying as Asian ethnic subgroups (eg, Korean, Vietnamese, and Thai), Other Pacific Islander ethnicities, (eg, Samoan, Micronesian, and Tongan), Black, and American Indian and Alaska Native.

Statistical Analysis
Data analysis was performed from 2020 to 2021. Statistical analyses were conducted with SAS, version 9.4 (SAS Institute Inc). All statistical tests were 2-sided, and P < .05 was considered statistically significant. Women with a primary DCIS diagnosis who developed an invasive SBC were compared with those who did not develop an invasive SBC. Two invasive SBC outcomes were separately evaluated: iiSBC and icSBC. The associations of patient and clinical factors with the risk of iiSBC and icSBC were evaluated by unconditional logistic regression to generate odds ratios (ORs) and 95% CIs. Factors (age, race and ethnicity, diagnosis year, DCIS histologic characteristics, laterality, hormone status, and treatment) that were significant on unadjusted analyses using the threshold of P < .05 were included in the adjusted models.

Factors Associated With iiSBC
On unadjusted analyses, age, race and ethnicity, year of diagnosis, histologic characteristics, and first course of treatment were each significantly associated with iiSBC and subsequently included in the adjusted analyses (

Factors Associated With icSBC
On unadjusted analyses, race and ethnicity, year of diagnosis, and histologic characteristics were each significantly associated with icSBC and subsequently included on adjusted analysis ( Table 3).
On adjusted analysis, an elevated risk for developing an icSBC was observed for Native Hawaiian

Discussion
In this study, we found that factors not previously reported, to our knowledge, were associated with the development of invasive SBC after an initial DCIS diagnosis. By using a more racially and ethnically diverse patient population compared with previous studies, we unmasked racial and ethnic disparities associated with developing an invasive SBC by disaggregating subpopulations of Asian American individuals and NHPI individuals. Our study found that Native Hawaiian and Filipino women had an increased likelihood of developing both iiSBC and icSBC compared with non-Hispanic White women and that Japanese women and younger women had an increased likelihood of developing iiSBC. Unlike previous studies, the cohort of women assessed here was more racially and ethnically diverse and had a large enough sample size to investigate historically overlooked US subpopulations.
The data underscore the importance of disaggregating higher-risk racial and ethnic subpopulations, particularly NHPI individuals who are often aggregated with Asian individuals or even excluded from cancer disparity research.  groups. 23 The Van Nuys Prognostic Index and subsequent iterations have been useful in identifying women at higher risk of developing SBC to guide decisions, such as the necessity for surgery and/or RT. 22 Race and ethnicity are important factors in estimating the risk of developing invasive SBC after DCIS. African American women have a high risk of developing invasive SBC and DCIS, both ipsilaterally and contralaterally. [6][7][8][9] Latina women have increased rates of developing subsequent ipsilateral DCIS. 6 Thus, there is increasing evidence to suggest that a patient's race and ethnicity are important prognosticators and may factor into clinical decision-making for patients who have received a diagnosis of an initial DCIS.

JAMA Network Open | Diversity, Equity, and Inclusion
Liu and colleagues 6 assessed 18 National Cancer Institute SEER registries and found that of the 9% of women who developed SBC after an initial noninvasive breast cancer diagnosis (70% of which were invasive SBC), Black and Asian women with DCIS had higher risks of developing biologically aggressive ipsilateral SBC compared with White women. They also reported that ipsilateral SBC occurred more often in Black and Hispanic women compared with White women. In their study, there were no statistical differences in ipsilateral SBC between White women and Asian American and NHPI (AAPI) women, with the AAPI ethnic subanalysis excluding Other Pacific Islander indivduals. This and many studies used the antiquated "AAPI" terminology that combines 2 groups legally disaggregated during the Clinton Administration, ultimately masking true cancer disparities for NHPI women. 11,15 Underrepresented US Populations In this study, we present data from one of the most ethnically unique US populations, with a large enough sample size to investigate smaller subsets of the US population. The state in which these data are derived, Hawai'i, has no ethnic majority and has the highest proportion of multiethnic individuals in the country. 24 The HTR contains the largest number of Native Hawaiian patients and is useful for disaggregating racial and ethnic data for these populations. Thus, the HTR has been curated with granular data to assess racial and ethnic US subpopulations, such as the Native Hawaiian subpopulation, that are underrepresented in other SEER databases.
Despite the existing evidence, it is poorly recognized that when they are properly disaggregated from Asian American individuals, NHPI women have higher morbidity and mortality rates for most cancers, including breast cancer, as well as other chronic diseases, compared with Asian American individuals. 14,15,17 The continued aggregation of Asian American individuals with NHPI individuals masks existing health disparities and further exacerbates health inequity. 11 For example, Torre and colleagues 16 highlight that Native Hawaiian women have nearly a 4-fold higher risk of breast cancer compared with some Asian ethnic subgroups. Cancer mortality among NHPI individuals is not improving, possibly owing to increased late-stage cancers among NHPI individuals. 25 Despite these high rates, there is minimal representation of NHPI individuals in clinical and genomic studies. 26 We found that Native Hawaiian women are at the highest risk of developing invasive SBC after a primary DCIS. Compared with White women, Native Hawaiian women had greater odds of developing iiSBC and icSBC. Although consistent with previous data highlighting the increased incidence rates of breast cancer among NHPI individuals, 27 our study specifically identifies Native Hawaiian race as a significant risk factor associated with the development of iiSBC and icSBC.
Understanding the underlying social determinants of health may explain in part why NHPI individuals have such high incidence rates of SBC and primary breast cancer in general. Native Hawaiian or Other Pacific Islander individuals have higher mean body size, greater adult-onset weight gain, and higher rate of tobacco and alcohol abuse, as well as more limited access to health care and poorer neighborhood socioeconomic status. 15,[28][29][30][31] Understanding these social determinants of health underscores the importance of proper disaggregation of Asian American and NHPI individuals.
In addition to Native Hawaiian women, our data also reveal that there are Asian subpopulations that disproportionately experience invasive SBC. Filipino women had a significantly higher likelihood of developing both iiSBC and icSBC compared with White women. Japanese women were also shown in this study to have an increased risk of developing an iiSBC. These data contrast with previous studies that have shown no increased risk of iiSBC in Asian ethnic subpopulations compared with White women. 6 These data highlight that there may be unappreciated heterogeneity within Asian subpopulations, which has been suggested previously. 14 It may be important to assess in future studies whether there are alternative categories other than a single Asian group (eg, Southeast Asian, East Asian, and South Asian).

Additional Factors: Age, Time, Treatment, and Laterality
Beyond race and ethnicity, previous studies have demonstrated other factors associated with an increased risk of developing SBC. We found that women younger than 50 years of age had greater odds of developing iiSBC compared with women 50 years of age or older. This association is consistent with a previous study that found that not only were younger women at an increased risk of developing iiSBCs but also had an associated increased mortality rate and more biologically aggressive tumor characteristics. 32 Younger women are typically healthier, with fewer comorbid conditions, and have longer life expectancies agnostic to their cancer diagnosis and thus reasonably have more life span to develop SBC. This is critical given that younger women with breast cancer have an associated 12-fold increased risk of death compared with the general population. 33 The time of initial DCIS diagnosis has multiple implications for the development of a subsequent SBC. We found that, after adjusting for confounders, the year of initial DCIS diagnosis was associated with the development of invasive SBCs. We found that, compared with the earlier time points (1973)(1974)(1975)(1976)(1977)(1978)(1979)(1980)(1981)(1982)(1983)(1984)(1985)(1986)(1987)(1988)(1989), women who received a diagnosis of breast cancer after 2000 had reduced odds of developing an invasive SBC. This finding may be due to the increasing prevalence of mammography screening between 1987 and 2000; screening rates increased from 29% to 70% during this period. 34 The ability to detect and localize smaller noninvasive tumors earlier may have affected clinical outcomes. Our observation of decreased odds of SBC in the 2010s compared with earlier decades is consistent with previous reports using national data. 10 Decreases in SBC risk in the later decades may also be explained in part by the development of new therapeutic strategies, including lumpectomy with adjuvant RT and endocrine therapy. [35][36][37][38] Treatment of DCIS includes mastectomy, BCS or lumpectomy, endocrine therapy, and RT. 5 Compared with BCS alone, RT in combination with BCS significantly reduces the chance of local recurrence 39 and may reduce overall breast cancer mortality. 38 Breast-conserving surgery alone has been shown to be associated with a 10-year local recurrence rate of 20% to 44%. Modern treatment augments BCS with either RT (50% reduction of local recurrence) and/or endocrine therapy (37% relative risk reduction of developing ipsilateral and contralateral SBC). 3,39 Although, in our study, we focused on the development of SBC rather than on local recurrence, for which data are not collected by SEER registries, we found that, compared with patients who underwent BCS alone, the odds of developing an iiSBC were reduced by approximately half in patients who received RT after BCS. We found that this was also true for patients who underwent mastectomy. In contrast, women who underwent no treatment had roughly double the odds of developing an iiSBC. This finding is also consistent with large national meta-analyses, suggesting the applicability of this database to national-level data. 3 Differences between the factors associated with iiSBC and the factors associated with icSBC have been previously investigated in the context of race and ethnicity. A previous report suggested a greater incidence of iiSBC among Black and Hispanic women but no difference in the aggregate Asian American and NHPI group. 6 In that study, like many others, the data were inappropriately aggregated into a single AAPI group. Thus, given that our data appropriately disaggregated NHPI individuals, we were able to investigate breast cancer disparities among NHPI individuals that have not been previously appreciated. As for icSBC, our data are consistent with a previous report suggesting that Asian American and NHPI individuals have higher rates of contralateral breast tumors. 6 Given our ethnically disaggregated findings, it may be the case that, in previous studies, some Asian subsets (eg, Filipino women) had disproportionately increased odds of developing icSBC, increasing the odds within the aggregate AAPI category.

Limitations
There are multiple limitations to this study. The generalizability of the study is important to take into consideration. The women in this study were all residents of Hawai'i and thus may not be representative of the entire US population. However, the comparison of Native Hawaiian women vs non-Hispanic White women still provides insight. This is especially true given that the National Cancer Institute SEER database used in this study has the largest number and the largest proportion of Native Hawaiian individuals represented in the data set. Although we focused on the 5 most represented racial and ethnic groups in the sample, Black, American Indian and Alaska Native, and Other Pacific Islander individuals were not represented with sufficient sample sizes for a meaningful statistical analysis. Subset data for groups with small numbers could not be shown to protect patient confidentiality. The lack of association with SBC risk observed for certain variables (ER status, PR status, and tumor grade) may have been influenced by their large proportion of missing values.

Conclusions
This cohort study suggests that Native Hawaiian women, Filipino women, and women who received a diagnosis of DCIS before 2000 have higher odds of developing both iiSBC and icSBC. It also suggests that women younger than 50 years and Japanese women have an increased risk for developing iiSBC. This study highlights racial and ethnic disparities in the risk of developing invasive SBC that were not, to our knowledge, previously appreciated among Native Hawaiian women and subpopulations of Asian American women compared with White women. This finding may help oncologists understand the association of race and ethnicity with the risk of developing invasive SBC in these understudied populations.